Company: STAA
Filing Date: 2025-09-30
Form Type: DEFA14A
Source: 0001193125-25-224160
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-09-30
Form: DEFA14A
Chunk 1
---
 prior to the
transaction announcement). The transaction represents a total equity value of approximately $1.5 billion.

“We are pleased to reach this
milestone towards the closing of our acquisition of STAAR. Together with STAAR, Alcon will be able to offer treatment options across the full spectrum of myopia, reinforcing our commitment to addressing the most significant needs in eye care,”
said David Endicott, CEO of Alcon.

“With the expiration of HSR, we are one step closer toward completing this value-maximizing transaction for
STAAR stockholders. In addition to providing our stockholders with compelling, certain, and premium cash value, Alcon’s resources will enable us to accelerate adoption of EVO ICL by surgeons and patients. We look forward to closing the
transaction and delivering to our stakeholders its many benefits,” said Stephen Farrell, CEO of STAAR.

Alcon and STAAR continue to anticipate that
the transaction will close within six to 12 months of the initial merger agreement announcement, which occurred on August 5, 2025, subject to customary closing conditions, including regulatory approval and approval by STAAR’s
stockholders.

STAAR will hold a virtual Special Meeting of Stockholders on October 23 at 8:30 a.m. (Pacific Time) to vote to adopt the Alcon merger proposal. Stockholders of record as of the close of business on September 12, 2025, are entitled to vote at the meeting. The STAAR Board of Directors unanimously recommends that all STAAR stockholders vote “FOR” the merger proposal on the “WHITE” proxy card TODAY.

1

STAAR stockholders with questions about voting their shares should contact STAAR’s proxy solicitor, Innisfree M&A Incorporated:

| • |     | For stockholders: +1 877-750-8233 
 (toll-free)                       |

| • |     | For banks and brokerage firms: +1 
 212-750-5833                      |

Morgan Stanley & Co. LLC is serving as financial advisor to Alcon, and Gibson, Dunn & Crutcher LLP is serving as legal advisor to Alcon. Citi is serving as the exclusive financial advisor to STAAR, and Wachtell, Lipton, Rosen & Katz is serving as legal advisor to STAAR. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight